Document Detail


Cellular cardiomyoplasty in acute myocardial infarction: where are we now?
MedLine Citation:
PMID:  18440658     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cellular cardiomyoplasty is an investigational technique that may have the potential to reduce myocardial infarct size and improve cardiac function in patients with ischemic heart disease. However, experience with this approach is still limited to a few small trials, some of which were not blinded or had other design problems. The mechanism of benefit, long-term safety, and clinical efficacy of cellular cardiomyoplasty require further study.
Authors:
Turgay Celik; Atila Iyisoy; U Cagdas Yuksel; Ersoy Isik
Related Documents :
8834928 - Ace inhibitors before or after heart failure?
15217918 - What mechanisms underlie diastolic dysfunction in heart failure?
12594448 - The problem of decompensated heart failure: nomenclature, classification, and risk stra...
10579068 - Myocardial revascularization for the treatment of post-ischemic heart failure.
9924168 - Implementation of serum cardiac troponin i as marker for detection of acute myocardial ...
18311068 - Reduction of ischemic, pharmacological and remote preconditioning effects by an antioxi...
Publication Detail:
Type:  Comment; Letter     Date:  2008-04-28
Journal Detail:
Title:  International journal of cardiology     Volume:  135     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-02     Completed Date:  2009-08-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  111-4; author reply 115-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary*
Combined Modality Therapy
Granulocyte Colony-Stimulating Factor / therapeutic use*
Humans
Myocardial Infarction / therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
143011-72-7/Granulocyte Colony-Stimulating Factor
Comments/Corrections
Comment On:
Int J Cardiol. 2007 Oct 31;122(1):41-7   [PMID:  17182126 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of specific serotonin reuptake inhibitors (SSRIs) (Sertraline or Citalopram) in the treatment of...
Next Document:  Assessing a landscape barrier using genetic simulation modelling: implications for raccoon rabies ma...